Webinar: Understanding Abuse Deterrent Opioids

On Thursday, December 8, at 1:00 p.m. ET, join the FDA’s Division of Drug Information for a webinar on abuse deterrent opioids. This is an important issue for health care providers, as they are often on the front lines in battling the current opioid epidemic. The webinar will cover:

  • Properties of abuse deterrent opioids
  • FDA’s evaluation and determination on labeling requirements
  • How abuse deterrent opioids impact health care providers

This session will be presented by FDA’s Director of Professional Affairs and Stakeholder Engagement John Whyte, MD, MPH. To register, please visit the FDA website.